Senior Data Architect, Cara Care
More information about location
Digital platform for gastrointestinal health
Be an early applicant
Digital platform for gastrointestinal health
21-100 employees
Be an early applicant
More information about location
21-100 employees
Company mission
To eradicate the stigma around gut health.
Jump to section
Company mission
To eradicate the stigma around gut health.
Our take
Cara Care, developed by HiDoc Technologies, provides a digital therapeutic app for gastrointestinal conditions such as IBS, reflux, and related digestive disorders. With gastrointestinal issues affecting a substantial share of adults globally, the company operates in a busy gut-health market driven by increasing awareness of the connection between diet, lifestyle, and digestive health.
The German startup faces competition from companies like ZOE, DayTwo, and Bowelle, but differentiates itself through its evidence-based approach combining food and symptom tracking, behaviour support, and guideline-aligned digital therapy for IBS.
A major development came in late 2024, when Bayer announced plans to acquire HiDoc Technologies and commercialise Cara Care as part of its broader digital therapeutics strategy. The deal supports wider international adoption and strengthens Cara Care's position within the growing market for clinically validated digestive health solutions.
Kirsty
Company Specialist at Welcome to the Jungle
Leadership
James Mapes
(CEO (of Bayer))Previously President & Chief Operating Officer at Centauri Health Solutions, CEO of Navigant Cymetrix, Executive VP of Genpact and was the Senior Vice President of Operations at Optum.